跳到主要內容

Cormorant Asset Management, LP 的 Form 4 申報

Corbus Pharmaceuticals Holdings, Inc.(CRBP),2024/9/24 申報

申報編號
0000929638-24-003217
申報時間
2024/9/24 16:04 ET
交易日
2024/9/20
申報延遲
4 天
10b5-1 計畫
沒有勾選

這份申報列了 6 筆非衍生性交易。公開市場買進合計 $700.4 萬。交易後 4 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Cormorant Asset Management, LPCIK 0001583977持股 10% 以上大股東
Chen BihuaCIK 0001599214持股 10% 以上大股東
Cormorant Global Healthcare Master Fund, LPCIK 0001618442持股 10% 以上大股東

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2024/9/20Common StockP買進取得+45,085$17.48F1+$787,860.382,070,085間接
2024/9/20Common StockP買進取得+25,943$18.36F3+$476,313.482,096,028間接
2024/9/20Common StockP買進取得+66,088$19.61F4+$1,296,051.772,162,116間接
2024/9/20Common StockP買進取得+139,551$20.42F5+$2,849,352.322,301,667間接
2024/9/20Common StockP買進取得+47,564$21.47F6+$1,021,389.342,349,231間接
2024/9/20Common StockP買進取得+25,769$22.23F7+$572,793.332,375,000間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $17.00 to $17.95 per share. The Reporting Persons undertake to provide, upon request by the staff of the Securities and Exchange Commission (the "SEC"), the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund (as defined below).

表 I 有 1 筆交易的價格引用這則附註。

F3

Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $18.03 to $18.999 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.

表 I 有 1 筆交易的價格引用這則附註。

F4

Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $19.00 to $19.998 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.

表 I 有 1 筆交易的價格引用這則附註。

F5

Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $20.00 to $20.995 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.

表 I 有 1 筆交易的價格引用這則附註。

F6

Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $21.00 to $21.99 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.

表 I 有 1 筆交易的價格引用這則附註。

F7

Represents the weighted average sale price of shares of common stock purchased in a series of open market transactions on the transaction date at prices ranging from $22.00 to $22.50 per share. The Reporting Persons undertake to provide, upon request by the staff of the SEC issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. All of these shares were purchased by the Master Fund.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)